Company Filing History:
5 out of 1,152 
2 out of 2 
1 out of 151 
Years Active: 2014-2025
Title: The Innovative Contributions of Markus Wolschek
Introduction
Markus Wolschek, an inventive mind based in Vienna, Austria, is recognized for his significant contributions to the field of virology and virus purification. With an impressive portfolio of 10 patents, he has developed innovative solutions that have the potential to enhance vaccine development and virus processing.
Latest Patents
Among his latest innovations, Wolschek's patent titled "Recombinant high growth rate influenza virus comprising mutations in M1, NS2, and PB2" focuses on the creation of reassortant influenza viruses. This invention details modifications in specific proteins (PB2, PB1, M1, and NS2) that lead to significantly increased growth rates compared to unmodified strains. The implications of this work are profound, particularly in the context of vaccination strategies aimed at combating influenza.
Another noteworthy patent is the "SO3 chromatography for use in a method for virus purification," which outlines a novel process for isolating virus particles from cell culture. This patent details a systematic approach including centrifugation, nuclease treatment, low conductivity buffer dilution, chromatography, washing, and elution of virus particles, enhancing the efficiency and effectiveness of virus purification processes.
Career Highlights
Wolschek has honed his expertise through his work with notable companies in the biotech and healthcare sectors. He spent significant periods at Baxter Healthcare and Bluesky Immunotherapies GmbH, where he applied his innovative thinking to develop solutions in healthcare and immunotherapy.
Collaborations
Throughout his career, Wolschek has collaborated with several esteemed professionals, including Andrej Egorov and Thomas Muster. These partnerships have fostered a rich environment for innovation, facilitating the exploration and development of cutting-edge technologies in virology.
Conclusion
Markus Wolschek's contributions to the field of virology through his patents and collaborative efforts reflect his commitment to advancing healthcare solutions. His innovative approaches not only underscored his prowess as an inventor but also highlighted the potential of his work to impact vaccine development and virus purification techniques. His achievements serve as an inspiration for current and future inventors in the biotechnological landscape.